185 related articles for article (PubMed ID: 38482253)
1. Upregulated expression of
He Y; Du Z; Peng H; Reddy AV; Cao P
J Gastrointest Oncol; 2024 Feb; 15(1):435-457. PubMed ID: 38482253
[TBL] [Abstract][Full Text] [Related]
2. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases.
Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y
Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325
[TBL] [Abstract][Full Text] [Related]
3. Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response.
Tian X; Xu WH; Xu FJ; Li H; Anwaier A; Wang HK; Wan FN; Zhu Y; Cao DL; Zhu YP; Shi GH; Qu YY; Zhang HL; Ye DW
Ann Med; 2022 Dec; 54(1):211-226. PubMed ID: 35037540
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance and potential regulatory mechanism of overexpression of pituitary tumor-transforming gene transcription factor in bladder cancer.
Li JD; Farah AA; Huang ZG; Zhai GQ; Wang RG; Liu JL; Wang QJ; Zhang GL; Lei ZL; Dang YW; Li SH
BMC Cancer; 2022 Jun; 22(1):713. PubMed ID: 35768832
[TBL] [Abstract][Full Text] [Related]
5. Low expression of bestrophin-2 is associated with poor prognosis in colon cancer.
Wang L; Zhu H; Sun W; Liang L; Li H; Han C; Huang W; Zhao B; Peng P; Qin M; Shi L; Mo Y; Huang J
Gene; 2022 Mar; 813():146117. PubMed ID: 34902511
[TBL] [Abstract][Full Text] [Related]
6. Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer.
Qi L; Zhou B; Chen J; Hu W; Bai R; Ye C; Weng X; Zheng S
J Cancer; 2019; 10(26):6618-6634. PubMed ID: 31777591
[No Abstract] [Full Text] [Related]
7. Necroptosis-Related Prognostic Model for Pancreatic Carcinoma Reveals Its Invasion and Metastasis Potential through Hybrid EMT and Immune Escape.
Liu H; Li Z; Zhang L; Zhang M; Liu S; Wang J; Yang C; Peng Q; Du C; Jiang N
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371833
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Significance and Potential Molecular Mechanism of
Chen SW; Zhou HF; Zhang HJ; He RQ; Huang ZG; Dang YW; Yang X; Liu J; Fu ZW; Mo JX; Tang ZQ; Li CB; Li R; Yang LH; Ma J; Yang LJ; Chen G
Front Genet; 2020; 11():583085. PubMed ID: 33552118
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of DHRS9 Overexpression in Pancreatic Cancer.
Li HB; Zhou J; Zhao F; Yu J; Xu L
Cancer Manag Res; 2020; 12():5997-6006. PubMed ID: 32765099
[TBL] [Abstract][Full Text] [Related]
10. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.
Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474
[TBL] [Abstract][Full Text] [Related]
11. PRR11 promotes cell proliferation by regulating PTTG1 through interacting with E2F1 transcription factor in pan-cancer.
Zhang H; He Z; Qiu L; Wei J; Gong X; Xian M; Chen Z; Cui Y; Fu S; Zhang Z; Hu B; Zhang X; Lin S; Du H
Front Mol Biosci; 2022; 9():877320. PubMed ID: 36060253
[TBL] [Abstract][Full Text] [Related]
12. Pituitary tumor transforming gene-1 in non-small cell lung cancer: Clinicopathological and immunohistochemical analysis.
Wang F; Liu Y; Chen Y
Biomed Pharmacother; 2016 Dec; 84():1595-1600. PubMed ID: 27829547
[TBL] [Abstract][Full Text] [Related]
13. [Pituitary tumor transforming gene 1 (PTTG1) is highly expressed and associated with poor prognosis in patients with hepatocellular carcinoma].
Tao H; Yang Y; Chen J; Lu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Apr; 36(4):337-343. PubMed ID: 32519672
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of desmoglein 2 and its clinical value in lung adenocarcinoma: a comprehensive analysis by multiple bioinformatics methods.
Sun R; Ma C; Wang W; Yang S
PeerJ; 2020; 8():e8420. PubMed ID: 32095325
[TBL] [Abstract][Full Text] [Related]
15. [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma].
Zheng J; Zhang YW; Pan ZF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):685-695. PubMed ID: 34728029
[TBL] [Abstract][Full Text] [Related]
16. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of pituitary tumor transforming gene 1 and transgelin-2 in pancreatic cancer.
Lin H; Chen QL; Wang XY; Han W; He TY; Yan D; Chen K; Su LD
Int J Immunopathol Pharmacol; 2013; 26(1):147-56. PubMed ID: 23527717
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis.
Fujii T; Nomoto S; Koshikawa K; Yatabe Y; Teshigawara O; Mori T; Inoue S; Takeda S; Nakao A
Hepatology; 2006 Jun; 43(6):1267-75. PubMed ID: 16628605
[TBL] [Abstract][Full Text] [Related]
19. Exploration and validation of downregulated microRNA-199a-3p, downstream messenger RNA targets and transcriptional regulation in osteosarcoma.
Huang WT; Liu AG; Cai KT; He RQ; Li Z; Wei QJ; Chen MY; Huang JY; Yan WY; Zhou H; Chen G; Ma J
Am J Transl Res; 2019; 11(12):7538-7554. PubMed ID: 31934299
[TBL] [Abstract][Full Text] [Related]
20. PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an integrated bioinformatics data analysis.
Huo Z; Zhai S; Weng Y; Qian H; Tang X; Shi Y; Deng X; Wang Y; Shen B
Onco Targets Ther; 2019; 12():5037-5051. PubMed ID: 31303762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
